{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:50:51Z","timestamp":1791435051544,"version":"4.3.3"},"reference-count":22,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Hypophosphatasia is a rare inherited metabolic bone disease caused by low activity of tissue-nonspecific alkaline phosphatase. Adult-onset hypophosphatasia is increasingly recognized, but fracture patterns and optimal management remain unclear. We report a 52-year-old woman who presented with progressive pain and bilateral atypical femoral fractures. She was diagnosed with hypophosphatasia based on low alkaline phosphatase, markedly elevated pyridoxal 5\u2032-phosphate, a history of metatarsal fracture, premature tooth loss, and pathogenic ALPL variants. Low-dose asfotase alfa was started because standard-dose therapy was not feasible. After 6 months, callus formation was observed, and pain improved. However, 6 months later, the pain recurred, and radiographs showed a progressive fracture, suggesting insufficient fracture healing. Staged intramedullary fixation was performed for both femurs. Two perioperative femoral fractures occurred during the course of surgical management. Therefore, adjunctive teriparatide (20 \u00b5g daily for six months) was initiated while continuing low-dose asfotase alfa. At 5-year follow-up, radiographic union of all femoral fractures was achieved, and the patient remained ambulatory without assistance and had no fracture-related pain. This case shows that adult-onset hypophosphatasia can cause severe skeletal fragility and may require individualized multidisciplinary management, including biochemical diagnosis, long-term radiographic surveillance, cautious surgical planning, and selective use of medication.<\/jats:p>","DOI":"10.3389\/fendo.2026.1909920","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:33:32Z","timestamp":1791434012000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Case Report: Atypical femoral fractures in adult-onset hypophosphatasia treated with low-dose asfotase alfa and adjunctive teriparatide therapy"],"prefix":"10.3389","volume":"17","author":[{"given":"Yoon-Sok","family":"Chung","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Metabolism, Ajou University School of Medicine","place":["Suwon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwang-Kyoun","family":"Kim","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Konyang University Hospital","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokul B.","family":"S.","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Sri Madhusudhan Sai Institute of Medical Sciences and Research","place":["Karnataka, India"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji-Seong","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, Konyang University Hospital","place":["Daejeon, Republic of Korea"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.bone.2017.02.011","article-title":"Hypophosphatasia: an overview for 2017","volume":"102","author":"Whyte","year":"2017","journal-title":"Bone"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-023-06844-1","article-title":"Hypophosphatasia diagnosis: current state of the art and proposed diagnostic criteria for children and adults","volume":"35","author":"Khan","year":"2024","journal-title":"Osteoporos Int"},{"key":"B3","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/978-94-017-7197-9_2","article-title":"Molecular genetics of hypophosphatasia and phenotype-genotype correlations","volume":"76","author":"Mornet","year":"2015","journal-title":"Sub-cell Biochem"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/s0021-9258(18)37885-2","article-title":"Structure of the human liver\/bone\/kidney alkaline phosphatase gene","volume":"263","author":"Weiss","year":"1988","journal-title":"J Biol Chem"},{"key":"B5","volume-title":"Strensiq [Package Insert]","year":"2018"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-02335","article-title":"Efficacy and safety of asfotase alfa in infants and young children with hypophosphatasia: a phase 2 open-label study","volume":"104","author":"Hofmann","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2015.02.022","article-title":"Hypophosphatasia: validation and expansion of the clinical nosology for children from 25 years experience with 173 pediatric patients","volume":"75","author":"Whyte","year":"2015","journal-title":"Bone"},{"key":"B8","article-title":"Adult hypophosphatasia treated with reduced frequency of teriparatide dosing","volume":"21","author":"Polyzos","year":"2021","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090731","article-title":"Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures","volume":"25","author":"Aspenberg","year":"2010","journal-title":"J Bone Miner Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20171377","article-title":"Four novel mutations in the ALPL gene in Chinese patients with odonto, childhood, and adult hypophosphatasia","volume":"38","author":"Xu","year":"2018","journal-title":"Biosci Rep"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1007\/s11999-009-1192-0","article-title":"Subtrochanteric femoral stress fractures after prolonged alendronate therapy","volume":"468","author":"Cermak","year":"2010","journal-title":"Clin Orthop Relat Res"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-021-05971-x","article-title":"Subtrochanteric atypical femoral fracture induced solely by glucocorticoid without bisphosphonate treatment: a case report","volume":"32","author":"Kim","year":"2021","journal-title":"Osteoporos Int"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1155\/2011\/521578","article-title":"An unusual presentation of primary hyperparathyroidism: pathological fracture","volume":"2011","author":"Khaoula","year":"2011","journal-title":"Case Rep Orthop"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-010-0203-2","article-title":"Insufficient bilateral femoral subtrochanteric fractures in a patient receiving imatinib mesylate","volume":"28","author":"Yang","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2018.12.011","article-title":"Five-year efficacy and safety of asfotase alfa therapy for adults and adolescents with hypophosphatasia","volume":"121","author":"Kishnani","year":"2019","journal-title":"Bone"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2020.115664","article-title":"Pharmacodynamics of asfotase alfa in adults with pediatric-onset hypophosphatasia","volume":"142","author":"Seefried","year":"2021","journal-title":"Bone"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.3298-19","article-title":"Effect of asfotase alfa on muscle weakness in a Japanese adult patient of hypophosphatasia with low ALP levels","volume":"59","author":"Koyama","year":"2020","journal-title":"Intern Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4158\/ACCR-2019-0143","article-title":"Adult-onset hypophosphatasia: before and after treatment with asfotase alfa","volume":"5","author":"Magdaleno","year":"2019","journal-title":"AACE Clin Case Rep"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-1902","article-title":"Adult hypophosphatasia treated with teriparatide","volume":"92","author":"Whyte","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1565","article-title":"Atypical femoral fractures during bisphosphonate exposure in adult hypophosphatasia","volume":"27","author":"Sutton","year":"2012","journal-title":"J Bone Miner Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.11138\/ccmbm\/2017.15.1.089","article-title":"Successful treatment of gonadotropin releasing hormone induced severe pregnancy and lactation-associated osteoporosis with teriparatide","volume":"15","author":"Tekantapeh","year":"2018","journal-title":"Clin cases Miner Bone Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-014-0617-3","article-title":"Healing of bisphosphonate-associated atypical femoral fractures in patients with osteoporosis: a comparison between treatment with and without teriparatide","volume":"33","author":"Miyakoshi","year":"2015","journal-title":"J Bone Miner Metab"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1909920\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T04:33:56Z","timestamp":1791434036000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1909920\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":22,"alternative-id":["10.3389\/fendo.2026.1909920"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1909920","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"article-number":"1909920"}}